Union Health Minister Shri J.P. Nadda Highlights India's Remarkable Progress in Reducing TB Mortality; Reiterates Resolve for TB-Mukt Bharat

1. At a Glance

• The headline: WHO's Global Tuberculosis Report 2026 shows India's TB mortality rate down 38% since 2015, against a 35% global decline. The Union Health Minister cited this on 13 Nov 2026 as proof of what the programme is achieving [1].
• Why it matters: The report measures results (deaths, treatment success), not just how many cases were notified. It credits active case finding, technology-led diagnostics, nutritional and community support and Jan Bhagidari [1].
• The policy framework: It all runs under the National TB Elimination Programme (NTEP) of the Ministry of Health and Family Welfare (MoHFW). India's elimination goal is set ahead of the global 2030 target [1][2].
• UPSC relevance: A fixed static base (NTEP, Ni-kshay schemes, NSP) plus fresh numbers each year (WHO GTR, World TB Day on 24 March) makes this a regular Prelims and GS-II/III topic [2][3].

2. Why in the News

• 13 Nov 2026: The Health Minister highlighted the WHO Global TB Report 2026 findings and restated the resolve for a TB-Mukt Bharat [1].
• Report figures: India's estimated TB mortality rate fell from 28 to 18 deaths per lakh population (2015→2025). Treatment success for drug-susceptible TB is 94% [1].
• Regional recognition: WHO SEARO (South-East Asia Regional Office) separately recognised India's progress [1].
• Earlier trigger: On World TB Day, 24 Mar 2026, a PIB backgrounder cited the WHO GTR 2025. It reported a 21% fall in incidence and a 28% fall in TB deaths over 2015–2024 [2].

3. Background & Evolution

• The programme's name: It was originally the Revised National Tuberculosis Control Programme (RNTCP). It was renamed NTEP in 2020 to signal the goal of eliminating TB before the global 2030 target [2][4].
• Milestones in order:
• Mar 2018: At the Delhi End TB Summit, the PM set the goal of ending TB in India by 2025 [4].
• Apr 2018: Ni-kshay Poshan Yojana (NPY) launched at ₹500/month paid by DBT for the whole course of treatment. It was later raised to ₹1,000/month, or ₹3,000–6,000 per patient over treatment [2][3].
• 2020: RNTCP was renamed NTEP [2]. The National Strategic Plan to End TB 2020–25 was announced in June 2020 on four pillars: Build, Prevent, Detect, Treat [2].
• 9 Sep 2022: President Droupadi Murmu launched the Pradhan Mantri TB Mukt Bharat Abhiyaan (PMTBMBA) together with the Ni-kshay Mitra initiative, in a spirit of Jan Bhagidari [2][4].
• 7 Dec 2024: The 100-Day TB Mukt Bharat Abhiyaan started in 347 high-priority districts across 33 States/UTs. It was later scaled up nationwide [1][2].

• Mar 2026: A further intensified campaign was launched [1].

• Earlier trend: The WHO GTR 2022 recorded incidence falling 18%, from 256 to 210 per lakh (2015→2021) [4].

4. Core Static Facts

5. Multi-Dimensional Analysis

Social

• Nutritional support (NPY) and community support (Ni-kshay Mitra) address undernutrition and poverty, which drive patients to drop out of treatment [1][2].
• Vulnerability mapping and systematic screening target high-risk groups instead of waiting for patients to come in [1][2].
• Framing the effort as a Jan Andolan brought in over 30,000 elected representatives and multiple line ministries [2].

Scientific / Technological

• Diagnosis tools: AI-enabled hand-held chest X-rays (500+ units deployed, 1,500 more being delivered) and rapid molecular diagnostics [1][2].
• AI is also used for cough screening, radiology reading and predictive analytics that flag high-risk patients [2].
• The BPaLM regimen cuts DR-TB treatment to 6 months [2].

Governance / Ethical

• Ni-kshay and DBT make it possible to monitor treatment and deliver benefits without leakage [1][2].
• Funding is 96% domestic, which shows sovereign ownership and resilience to swings in donor funding [1].

Administrative

• Districts were prioritised (347 in the 100-day phase) before the campaign went nationwide [2].
• Panchayat certification creates local accountability. 46,118 GPs were certified TB-free for 2024 [2] and 67,933 Panchayats for 2025 [1].
• Ongoing challenge: the 2025 elimination goal, set five years ahead of the SDG deadline, has been pushed toward 2030. Falling rates of decline do not equal elimination [2][3].

Economic

• Finding cases early cuts catastrophic health spending and lost productivity. NPY's direct cash support adds to this effect [2].

6. Recent Developments (last 12–18 months)

• 7 Dec 2024 onward: Since the Abhiyaan began, over 20 crore vulnerable people have been screened. More than 28 lakh patients were diagnosed, including 9 lakh asymptomatic cases (as of Mar 2026) [2].
• 24 Mar 2026 (World TB Day): The GTR 2025 data showed incidence down 21% and deaths down 28% over 2015–24 [2].
• Mar 2026: A further intensified TB Mukt Bharat campaign was launched [1].
• 2025: 67,933 Panchayats were declared TB-free [1].
• Intensified screening (cumulative): 48.64 lakh cases detected, of which 14.97 lakh were asymptomatic [1].
• 13 Nov 2026: The GTR 2026 showed India's mortality falling 38% vs 35% globally, with treatment success at 94% [1].

7. Prelims Hooks

• RNTCP was renamed NTEP in 2020 [2].
• Ni-kshay Poshan Yojana launched in April 2018. Assistance was raised from ₹500 to ₹1,000/month [2][3].
• PMTBMBA was launched by President Droupadi Murmu on 9 Sep 2022 [4].
• The Ni-kshay Mitra initiative was launched alongside PMTBMBA [4].
• The 100-Day TB Mukt Bharat Abhiyaan started on 7 Dec 2024 in 347 districts, 33 States/UTs [2].
• The four pillars of the NSP to End TB 2020–25 are Build, Prevent, Detect, Treat [2].
• India's TB mortality rate fell from 28 to 18 per lakh (2015→2025), a 38% drop vs 35% globally (WHO GTR 2026) [1].
• India's TB incidence fell from 237 to 187 per lakh (2015→2024), a 21% drop (WHO GTR 2025) [2].
• Treatment success for drug-susceptible TB is 94% (GTR 2026) [1].
• 96% of TB programme funding comes from domestic resources [1].
• BPaLM = Bedaquiline + Pretomanid + Linezolid + Moxifloxacin, a 6-month regimen for DR-TB [2].
• JOSH Teams bring together officials, NCC cadets and MY Bharat volunteers [1].
• World TB Day is observed on 24 March [2].
• The goal of ending TB by 2025 was announced at the Delhi End TB Summit, March 2018 [4].

8. Why a 38% Fall Does Not Mean TB Is Nearly Gone

• A falling rate is not the same as fewer deaths
• The mortality rate is deaths per lakh people. It fell from 28 to 18 per lakh between 2015 and 2025 [1].
• India's population grew over those ten years. So the rate falls faster than the actual number of deaths.

• That is why the GTR 2025 figure for the fall in deaths (28%) is lower than the GTR 2026 figure for the fall in the rate (38%) [1][2].

• WHO changed India's starting number between reports

• GTR 2022 put India's 2015 incidence (new cases per lakh people each year) at 256 per lakh [4].
• GTR 2025 put the same year, 2015, at 237 per lakh [2].

• So the base year was revised downward. A "% fall since 2015" from one report cannot be compared directly with a "% fall" from another report.

• The mortality figure moved ten points in one extra year

• Deaths fell 28% over 2015–24 (GTR 2025) [2]. The rate fell 38% over 2015–25 (GTR 2026) [1].
• WHO figures for India are estimates, not a count of every death. A jump this big in one year can come partly from WHO revising its estimates, not only from fewer people dying.

• In an answer, quote each figure with its report year and time span. Do not join them into one trend.

• Faster than the world is still far from the goal

• Incidence in 2024 was still 187 per lakh [2].
• The 2025 elimination goal announced at the 2018 Delhi End TB Summit was missed, and the target has moved toward 2030 [2][4].
• Beating the global average (35%) shows the direction is right. It does not show India is close to elimination [1].

9. Who the Success Figures Leave Out

• 94% treatment success counts only patients the system already knows about
• Treatment success is measured among notified patients, meaning those officially registered on Ni-kshay [1].
• A patient who is never diagnosed, or who is treated privately and never reported, is not in the denominator (the group the percentage is calculated from).

• So a high success rate can sit next to a large number of people with untreated TB.

• About one in three cases found by screening had no symptoms

• Intensified screening found 48.64 lakh cases. 14.97 lakh of them, about 31%, were asymptomatic (no cough, fever or other complaints) [1].
• The earlier Abhiyaan data show the same pattern: 9 lakh of 28 lakh, about 32% [2].
• The old system waited for sick people to come to a clinic. These people would never have come, so they were missed for years.

• This is the strongest evidence that active case finding (going out to test people instead of waiting) works. It also shows how much the old way of measuring cases missed.

• Private-sector under-reporting is not measured in the official figures

• Indonesia ran an inventory study, which matches diagnosed TB cases in hospitals and labs against the official register. It found under-reporting fell from 41% (2017) to 15.6% (2023), and was much higher in private facilities [8].
• The PIB sources for India give notification and success figures but no matching estimate of how many privately diagnosed cases are never reported [1][2].

10. Where the Programme Breaks Down on the Ground

• Field supervisor posts lie vacant
• The 2016 TB technical guidelines require one Senior Treatment Supervisor (STS) and one Senior Treatment Laboratory Supervisor (STLS) for every TB Unit covering 1.5–2.5 lakh people [6].
• CAG found some of these posts vacant in sampled Delhi districts, and no full-time Medical Officer for TB Control at the clinic it checked [6].

• These are the staff who follow up patients and check lab quality. If the post is empty, a patient who stops treatment is not traced.

• Drug-resistant TB oversight was set up late or not at all

• CAG's Delhi audit (Report No. 3 of 2024) found District DR-TB Committees not formed or formed late, and weak monitoring of the scheme [5].

• DR-TB (TB that does not respond to the usual drugs) needs the closest follow-up. The BPaLM regimen only helps if someone tracks each patient for the full 6 months [2].

• Auditors doubted the 2025 goal before it was missed

• A 2024 CAG audit of centrally sponsored schemes found NTEP implementation deficient in the state it examined. It said the 2025 elimination goal looked uncertain [7].

• The NPY figure counts money paid, not money paid in time

• PIB reports ₹4,454.68 crore paid to 1.38 crore beneficiaries [2].

• Nutrition support matters most in the first months of treatment, when patients are weakest and most likely to drop out. A total amount paid does not show whether the cash arrived during that period.

• TB-free certification can clash with case finding

• 67,933 Panchayats were declared TB-free for 2025 [1]. At the same time, the campaign is asking villages to find more hidden cases [1][2].
• If being called "TB-free" depends on reporting few cases, a Panchayat gains nothing by finding more. The certification rules have to reward finding cases, not hiding them.

11. What Should Follow, and Who Should Do It

• MoHFW should publish an inventory study of private-sector reporting
• Indonesia did this twice, so it can show under-reporting falling from 41% to 15.6% with evidence [8].

• An Indian study would show how many diagnosed patients the 94% success rate leaves out [1].

• State health departments should fill STS and STLS posts first

• CAG found these posts vacant against the 2016 norm [6].

• Screening finds the cases, but these staff keep the patients on treatment. Without them, more case finding only adds patients who drop out.

• District Collectors should form and run District DR-TB Committees

• CAG flagged their absence or delay in Delhi [5].

• Every patient on BPaLM should be reviewed by a named committee each month [2].

• The Ni-kshay portal should report how fast NPY cash arrives, not only the total paid

• The system already pays by DBT through Ni-kshay [1][2]. It can also show the time from notification to first payment, district by district.

• The Ministry of Panchayati Raj and MoHFW should link TB-free status to screening coverage

• Certify a Panchayat only after it shows a minimum level of screening of vulnerable groups [1][2]. Then a low case count means TB is actually low, not just that nobody looked.

• WHO and MoHFW figures should be quoted with report year and time span

• This avoids presenting a revised baseline (256 vs 237 per lakh for 2015) as real progress [2][4].

12. Anchors for Answers

• Data: TB mortality rate down from 28 to 18 per lakh (2015→2025), a 38% fall vs 35% globally, WHO GTR 2026 [1]
• Data: About 31% of intensified-screening cases (14.97 lakh of 48.64 lakh) were asymptomatic, which shows how many cases a clinic-based system missed [1]
• Data: WHO revised India's 2015 baseline incidence from 256 (GTR 2022) to 237 per lakh (GTR 2025) [2][4]
• Report/Committee: CAG Report No. 3 of 2024, Performance Audit of Public Health Infrastructure, Delhi: District DR-TB Committees not formed or delayed, weak monitoring [5]; STS/STLS and TB Medical Officer posts vacant [6]
• Report/Committee: CAG 2024 audit of centrally sponsored schemes: NTEP implementation deficient in the audited state, 2025 elimination goal uncertain [7]
• Comparison: Indonesia's second national TB inventory study measured under-reporting falling from 41% (2017) to 15.6% (2023), highest in private facilities [8]
• Scheme: Ni-kshay Poshan Yojana, ₹1,000/month by DBT. It tackles the undernutrition that pushes patients to drop out, but official totals do not show how quickly the cash arrives [2]

13. Mains Relevance

• GS-II: Health; government policies and interventions; issues relating to development and management of social sectors; vulnerable sections.
• GS-III: Science & technology in everyday life (AI diagnostics, digital health); inclusive growth.
• Possible question stems: 1. India's TB mortality is declining faster than the global average, yet elimination remains elusive. Critically examine the gaps in the National TB Elimination Programme. (GS-II, 15 marks) 2. Active case finding and asymptomatic TB detection mark a shift in public health strategy. Discuss their role, with reference to the TB Mukt Bharat Abhiyaan. (GS-II, 10 marks) 3. Evaluate the role of community participation and nutritional support in improving TB treatment outcomes in India. (GS-II, 15 marks)

14. Related Topics to Study Next

• SDG 3.3 and WHO's End TB Strategy: These set the 2030 global benchmark that India's goal is measured against.
• Drug-resistant TB (MDR/XDR) and AMR: The BPaLM regimen and the antimicrobial-resistance policy link.
• Ayushman Bharat and Ayushman Arogya Mandirs: The primary-care platform for screening and follow-up.
• Ayushman Bharat Digital Mission: Ni-kshay as an early example of a digital public health platform.
• POSHAN Abhiyaan and the link between undernutrition and TB: The rationale for NPY.
• MY Bharat and NCC: The youth bodies behind JOSH Teams and Ni-kshay Mitra volunteering.
• Other disease-elimination drives (kala-azar, lymphatic filariasis, leprosy): Comparable elimination-mode programmes.
• Panchayati Raj (73rd Amendment): The TB-Mukt Panchayat certification as local health governance.

15. NCERT Concepts to Revise

• National TB Elimination Programme (Economy): The umbrella programme (formerly RNTCP) under which all the note's schemes, screening and diagnostics run.
• Tuberculosis (Economy): The disease at the centre of the note: how it spreads and why undernutrition raises risk.
• Ni-kshay Poshan Yojana (Economy): Cash nutrition support for TB patients, paid by DBT, to reduce treatment dropout.
• Ni-kshay Mitra (Economy): Community adoption of patients, launched 2022; easily confused with the Poshan Yojana and the portal.
• Drug-resistant tuberculosis (Economy): Explains why DR-TB needs the BPaLM regimen and closer follow-up, as CAG found lacking.
• Incidence (Economy): New cases per lakh people; the note's 237 to 187 fall and revised baseline depend on it.
• Mortality rate (Economy): Deaths per population; helps separate the 38% fall in rate from the 28% fall in deaths.
• WHO End TB Strategy (Economy): Sets the 2030 global targets that India's 2025 goal is measured against.
• Sustainable Development Goal 3 (Economy): The global health goal, including ending TB, behind the 2030 benchmark.
• Direct Benefit Transfer (Polity): How nutrition cash reaches patients through Ni-kshay without leakage.
• Comptroller and Auditor General (Polity): The CAG audits cited in the note found vacancies and weak DR-TB oversight.
• Panchayati raj (Polity): Villages are certified TB-free, making local bodies part of programme accountability.
• Ayushman Bharat Digital Mission (Economy): Digital health ecosystem in which Ni-kshay is an early example of tracking patients.
• POSHAN Abhiyaan (Economy): National nutrition mission that addresses the undernutrition-TB link behind NPY.

16. Common Errors / Trap Areas

• Rate vs reduction: 28→18 per lakh is a level. 38% is the change. Also, the 28% fall in deaths (GTR 2025, 2015–24) [2] is a different figure from the 38% fall in the mortality rate (GTR 2026, 2015–25) [1].
• Three different "Ni-kshay"s: Ni-kshay is the digital portal. Ni-kshay Poshan Yojana is cash for nutrition via DBT, launched 2018. Ni-kshay Mitra is donor and community support, launched 2022 [1][2][4].
• Who launched PMTBMBA: It was the President (9 Sep 2022), not the PM. The PM's 2018 End TB Summit announced the 2025 goal [4].
• NSP years: PIB papers give both "2017–25" [3] and "2020–25, announced June 2020" [2]. Read the option wording carefully.
• Two treatment-success figures: 94% is for drug-susceptible TB in WHO GTR 2026 [1]. 90% is under the Abhiyaan, against a global 88% (Mar 2026) [2]. WHO's global report is also not the same as WHO SEARO's regional recognition [1].